Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens

• Cirino Botta,
• Enrica Antonia Martino,
• Concetta Conticello,
• Francesco Mendicino,
• Ernesto Vigna,
• Alessandra Romano,
• Giuseppe Antonio Palumbo,
• Claudio Cerchione,
• Giovanni Martinelli,
• Fortunato Morabito,
• Francesco Di Raimondo,
• Massimo Gentile

Affiliations

Cirino Botta

Hematology Unit, “Annunziata” Hospital of Cosenza, Cosenza, Italy

Enrica Antonia Martino

Hematology Unit, “Annunziata” Hospital of Cosenza, Cosenza, Italy

Concetta Conticello

Division of Hematology, AOU Policlinico, Catania, Italy

Francesco Mendicino

Hematology Unit, “Annunziata” Hospital of Cosenza, Cosenza, Italy

Ernesto Vigna

Hematology Unit, “Annunziata” Hospital of Cosenza, Cosenza, Italy

Alessandra Romano

Department of Medical and Surgical Sciences and Advanced Technologies “G.F. Ingrassia”, University of Catania, Catania, Italy

Giuseppe Antonio Palumbo

Department of Medical and Surgical Sciences and Advanced Technologies “G.F. Ingrassia”, University of Catania, Catania, Italy

Claudio Cerchione

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

Giovanni Martinelli

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

Fortunato Morabito

Hematology and Bone Marrow Transplant Unit, Hemato-Oncology Department, Augusta Victoria Hospital, East Jerusalem, Israel

Francesco Di Raimondo

Department of Medical and Surgical Sciences and Advanced Technologies “G.F. Ingrassia”, University of Catania, Catania, Italy

Massimo Gentile

Hematology Unit, “Annunziata” Hospital of Cosenza, Cosenza, Italy